dr. antonarakis on sequencing adt and sipuleucel-t in biochemically recurrent prostate cancer
Published 11 years ago • 137 plays • Length 3:21Download video MP4
Download video MP3
Similar videos
-
1:42
dr. emmanuel antonarakis on sequencing adt and sipuleucel-t
-
1:20
dr. antonarakis on ar-v7 and resistance to enzalutamide and abiraterone in prostate cancer
-
3:05
nabid: short-term adt in intermediate prostate cancer
-
2:26
monitoring response to adt in prostate cancer
-
1:32
dr. antonarakis discusses ar-v7 and response to taxanes in men with mcrpc
-
6:40
considerations for initiating adt in prostate cancer
-
3:50
considering adt’s role in advanced prostate cancer
-
1:05
dr. shore on challenges with adt in recurrent prostate cancer
-
0:53
dr. cooperberg comments on earlier prostate cancer treatment with sipuleucel-t
-
1:24
dr. antonarakis on galeterone for prostate cancer
-
1:56
arasens: dialuramide plus adt and docetaxel for metastatic hormone-sensitive prostate cancer
-
4:43
adt as treatment in metastatic prostate cancer
-
9:54
adt and cardiovascular risk in prostate cancer: q&a
-
4:12
optimal adt for patients with prostate cancer and cv history
-
8:34
predictors of adt response in advanced prostate cancer.
-
1:57
dr. sandler discusses hypofractionation in prostate cancer
-
5:59
challenges associated with adt for prostate cancer
-
2:05
startar: adt with apalutamide, radiation therapy and docetaxel in prostate cancer
-
1:53
dr. nguyen on the optimal duration of adt in high-risk prostate cancer